A investpharm - Company finances
|
EUR
|
2022
From: 2022-01-20
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 18,206 | 23,500 | 8,312 |
| Profit before tax | -363 | 585 | 2,667 | 375 |
| Net profit | -363 | 574 | 2,534 | 315 |
| Equity | 2,137 | 2,711 | 5,245 | 5,560 |
| Liabilities | 363 | 9,819 | 247 | 7,635 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 2,500 | 12,530 | 5,492 | 13,195 |
| Total assets | 2,500 | 12,530 | 5,492 | 13,195 |
|
Taxes paid
|
||||
| STI taxes | - | - | 11 | 133 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +29.1% | -64.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -14.5% | 4.6% | 46.1% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -17.0% | 21.2% | 48.3% | 5.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 3.2% | 10.8% | 3.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 3.2% | 11.3% | 4.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 3.6 | 0.0 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 18,206 | 23,500 | 8,312 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
A investpharm - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-22 | 0.75 |
| 2025-09-16 | 2025-09-22 | 0.90 |
| 2024-12-17 | 2024-12-20 | 1.37 |
A investpharm - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
A investpharm, UAB (company code 305987591) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €8.3K and recorded net profit of €315, resulting in a profit margin of 3.8%. This was a weaker year than 2024, when revenue reached €23.5K and net profit €2.5K, after €18.2K of revenue and €574 of net profit in 2023. Over the two-year period to 2025, revenue declined by 54.3%, and the year-on-year drop in 2025 was 64.6%. Despite the lower turnover, the balance sheet remained positive, with total assets of €13.2K, equity of €5.6K and liabilities of €7.6K at the end of 2025. Key ratios for 2025 show a return on equity of 5.7%, return on assets of 2.4%, debt-to-equity of 1.37 and asset turnover of 0.63x. Revenue per employee was €8.3K, with profit per employee of €315.